Podcast Episodes
Back to Search
Ep. 286 - Sofinnova’s Pan-European Accelerator, China Biotechs, Trump Tariffs
Season 6 Episode 286
European venture firm Sofinnova Partners is expanding the reach of its Biovelocita accelerator beyond Italy to stretch across the greater continent. …
1 year, 5 months ago
Ep. 285 - BIO's Trump 2.0 Plan. Plus: Autoimmune CAR Ts & Telix's Radiopharma Play
Season 6 Episode 285
BIO is engaging with President Donald Trump to protect and improve FDA. It’s also hoping biopharmas can dodge tariffs and find paths to modify the In…
1 year, 5 months ago
Ep. 284 - Takeaways from the East-West Summit
Season 6 Episode 284
While the culling of companies in the biotech bear market may have yet to subside, creative cross-border deal-making on innovative assets is spreadin…
1 year, 5 months ago
Ep. 283 - Makary’s FDA Agenda, Amylin in Obesity and Life After DEI
Season 6 Episode 283
The almost certain confirmation of Marty Makary as FDA commissioner this month will cap a transition marked by internal upheaval and political infigh…
1 year, 5 months ago
Ep. 282 - CRISPR Lessons: Plus, AbbVie Enters Obesity
Season 6 Episode 282
The track record of biotechs launched to create curative therapies using CRISPR-Cas9 provides new insights into the old debate over whether platform …
1 year, 6 months ago
Ep. 281 - Roche Reboot and 5 Things on Trump 2.0
Season 6 Episode 281
Once pharma’s oncology powerhouse, Roche is charting a new course that extends beyond its traditional stronghold in cancer therapeutics. On the lates…
1 year, 6 months ago
Ep. 280 - China Competition. Plus: FDA Firings and Biotech IPOs
Season 6 Episode 280
Rather than fretting over increasing competition from Chinese life sciences companies, biotechs in the U.S. should rise to the challenge and learn fr…
1 year, 6 months ago
Ep. 279 - East-West Summit Preview
Season 6 Episode 279
Western VCs are paying more attention than ever to innovation emerging from Asia — from antibody-drug conjugates to bispecifics, AI and beyond — as t…
1 year, 6 months ago
Ep. 278 - Trump 2.0’s Impact on FDA, NIH. Plus: Precision Medicine
Season 6 Episode 278
White House plans to slash FDA and NIH risk decimating two agencies at the core of U.S. biomedical innovation. On the latest BioCentury This Week pod…
1 year, 6 months ago
Ep. 277 - Asia's NewCo Model, FDA Tipping Point, Vertex's Pain Drug
Season 6 Episode 277
The boom in the creation of companies that were launched in the West based on assets sourced in Asia signals China’s galloping speed of innovation. O…
1 year, 7 months ago